Portal de Periódicos da CAPES

Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus

2006; Informa; Volume: 38; Issue: 4 Linguagem: Inglês

10.1080/00365540500372697

1651-1980

Suresh J. Antony,

Bacterial Identification and Susceptibility Testing

Methicillin-resistant Staphylococcus aureus (MRSA) infections are commonly treated with vancomycin (VAN) or another glycopeptide antibiotic. However, when vancomycin fails or infections recur, there are few other therapeutic options. Presented here are 2 cases where a novel combination of daptomycin, vancomycin, and rifampin resolved recurrent MRSA bone and prosthetic joint infections.